Role of T-H 17 Responses in Increasing Herpetic Keratitis in the Eyes of Mice Infected with HSV-1
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
Authors: Hirose, Satoshi; Jaggi, Ujjaldeep; Wang, Shaohui; Tormanen, Kati; Nagaoka, Yoshiko; Katsumata, Makoto; Ghiasi, Homayon
Abstract
PURPOSE. T(H)17 cells play an important role in host defense and autoimmunity yet very little is known about the role of IL17 in herpes simplex virus (HSV)-1 infectivity. To better understand the relationship between IL17 and HSV-1 infection, we assessed the relative impact of IL17A-deficiency and deficiency of its receptors on HSV-1 responses in vivo. METHODS. We generated IL17RA(-/-) and IL17RA(-/-) RC-/- mice in-house and infected them along with IL17RA(-/-) and IL17RC(-/-) mice in the eyes with 2 x 10(5) PFU/eye of wild type (WI) HSV-1 strain McKrae. WT C57BL/6 mice were used as control. Virus replication in the eye, survival, corneal scarring (CS), angiogenesis, levels of latency-reactivation, and levels of CD8 and exhaustion markers (PD1, TIM3, LAGS, CTLA4, CD244, and CD39) in the trigeminal ganglia (TG) of infected mice were determined on day 28 postinfection. RESULTS. No significant differences in virus replication in the eye, survival, latency, reactivation, and exhaustion markers were detected among IL17A(-/-), IL17RA(-/-), IL17RC(-/-), IL17RA(-/-), and WT mice. However, mice lacking IL17 had significantly less CS and angiogenesis than WT mice. In addition, angiogenesis levels in the absence of IL17RC and irrespective of the absence of IL17RA were significantly less than in IL17A- or IL17RA-deficient mice. CONCLUSIONS. Our results suggest that the absence of IL17 protects against HSV-1-induced eye disease, but has no role in protecting against virus replication, latency, or reactivation. In addition, our data provide rationale for blocking IL17RC function rather than IL17A or IL17RA function as a key driver of HSV-1-induced eye disease.
MCPIP1 RNase Is Aberrantly Distributed in Psoriatic Epidermis and Rapidly Induced by IL-17A
JOURNAL OF INVESTIGATIVE DERMATOLOGY
Authors: Ruiz-Romeu, Ester; Ferran, Marta; Gimenez-Arnau, Ana; Bugara, Beata; Lipert, Barbara; Jura, Jolanta; Florencia, Edwin F.; Prens, Errol P.; Celada, Antonio; Pujol, Ramon M.; Santamaria-Babi, Luis F.
Abstract
ZC3H12A, which encodes the RNase monocyte chemotactic protein-induced protein 1 (MCPIP1), is upregulated in psoriatic skin and reduced to normal levels after clinical treatments with anti-IL-17A/IL-17R neutralizing antibodies. In IL-17A-stimulated keratinocytes, MCPIP1 is rapidly increased at the transcript and protein levels. Also, IL-17A was found to be the main inducer of ZC3H12A expression in keratinocytes treated with supernatants derived from a Streptococcus pyogenes-activated psoriatic ex vivo model based on the co-culture of psoriatic cutaneous lymphocyte-associated antigen (CLA(+)) T cells and lesional epidermal cells. Moreover, MCPIP1 was aberrantly distributed in the suprabasal layers of psoriatic epidermis. In psoriatic samples, IL-17A-stimulated epidermal cell suspensions showed an increased MCPIP1 expression, especially in the mid-differentiated cellular compartment. The knockdown of ZC3H12A showed that this RNase participates in the regulation of the mRNAs present in suprabasal differentiated keratinocytes. Furthermore, JAK/STAT3 inhibition prevented the IL-17A-dependent induction of MCPIP1. In the mouse model of imiquimod-induced psoriasis, Zc3h12a expression was abrogated in Il17ra(-/-) mice. These results support the notion that IL17A-mediated induction of MCPIP1 is involved in the regulation of local altered gene expression in suprabasal epidermal layers in psoriasis.